Related Experiment Video
Updated: Jul 28, 2026

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
Published on: July 5, 2021
Otogenic Central Skull Base Osteomyelitis With Retropharyngeal Extension: A Case Report
Regina Jacobo-Pinelli1, Jose Alberto Guerrero-Paz1, Juan Antonio Lugo-Machado1
1Otolaryngology, Hospital de Especialidades No. 2 Instituto Mexicano del Seguro Social (IMSS), Ciudad Obregón, MEX.
Abstract:
Skull base osteomyelitis (SBO) is a life-threatening condition in patients with underlying comorbidities. Ear infections may spread through normal skull base fissures in this group of patients. However, its diagnosis is frequently delayed due to the unspecific clinical findings at onset, such as headache, with diverse cranial neuropathies later as the disease progresses. We present the case of a patient with otogenic skull base osteomyelitis complicated with retropharyngeal extension, treated with surgical drainage and broad-spectrum antibiotics directed toward extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli, with recurrence of the infection three months later. With this case study, we aim to stress the importance of antimicrobial resistance and how it can preclude an otherwise favorable prognosis.
Insights
Skull base osteomyelitis (SBO) is a severe infection often diagnosed late. Antimicrobial resistance in pathogens like E. coli can complicate treatment and worsen patient prognosis.
Area of Science:
- Infectious Diseases
- Otolaryngology
- Neurosurgery
Background:
- Skull base osteomyelitis (SBO) is a serious infection, particularly in patients with comorbidities.
- Otogenic infections can spread through skull base fissures, leading to SBO.
- Diagnosis is often delayed due to non-specific initial symptoms like headache.
Observation:
- A case of otogenic SBO with retropharyngeal extension is presented.
- The patient was treated with surgical drainage and broad-spectrum antibiotics targeting ESBL-producing E. coli.
- The infection recurred three months post-treatment.
Findings:
- Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli can cause recurrent SBO.
- Antimicrobial resistance poses a significant challenge in managing SBO.
- Successful treatment may be hindered by resistant bacterial strains.
Implications:
- Highlights the critical role of antimicrobial stewardship in managing SBO.
- Emphasizes the need for early diagnosis and appropriate antibiotic selection.
- Underscores the impact of antimicrobial resistance on patient outcomes in SBO.
Related Concept Videos
Bacterial Meningitis I: Introduction
Brain Abscess l: Introduction

